While a small sampling, BIO’s third diversity report provides ‘benchmark’ for data-focused industry to further analyze

The numbers are somewhat in and biotech diversity looks relatively similar to what it has been for years.

A 2021 sampling paints a very limited picture of the industry, with BIO’s third annual diversity report including only 99 respondent companies. Most questions were not or could...

Click to view original post